Association between sex hormones regulation‐related SNP rs12233719 and lung cancer risk among never‐smoking Chinese women

Ying Qian, Li Xie, Lei Li, Tienan Feng, Tengteng Zhu, Ruoyang Wang, Yuqing Yang, Baosen Zhou, Herbert Yu, Biyun QianCancer 2021 · DOI

TL;DR

This study identifies a specific genetic variation (SNP rs12233719) in the UGT2B7 gene as a risk factor for lung cancer in never-smoking Chinese women. This finding offers a potential explanation for the higher incidence of lung cancer in this demographic and highlights the role of sex hormone regulation in lung cancer susceptibility.

What Problem Does This Paper Address?

Lung cancer is a leading cause of cancer death globally, and its incidence in never-smoking women, particularly in China, is alarmingly high and not well understood. While genetic factors, lifestyle, and environmental exposures are known contributors, the specific mechanisms driving this trend in never-smoking women remain elusive. Previous research has suggested a protective role for ovarian sex steroid hormones in counteracting lung cancer development, and sex hormone-binding globulin (SHBG) is crucial for regulating these hormones. This paper aims to investigate whether genetic variations within genes involved in SHBG regulation and sex hormone metabolism contribute to the susceptibility of never-smoking Chinese women to non-small cell lung cancer (NSCLC).

Methods

The researchers employed a two-stage case-control study design.

  • Candidate Gene and SNP Selection: They began by identifying 12 genomic regions previously associated with circulating SHBG concentrations. This was combined with transcriptome sequencing data from never-smoking female NSCLC patients to find genes differentially expressed in tumor tissues. After filtering for genes related to SHBG and sex hormone regulation, the UGT2B7 gene emerged as a key candidate. From UGT2B7, they selected single nucleotide polymorphisms (SNPs) that were common, missense variants, showed ethnic heterogeneity, and had a minor allele frequency (MAF) greater than 0.05 in the Chinese Han population. This process led to the identification of two candidate SNPs: rs12233719 and rs7439366.
  • Genotyping: The selected SNPs were genotyped using the TaqMan method.
  • Case-Control Study: A two-stage design was used:
  • Stage 1 (Training): A case-control study was conducted in Shenyang, China, with 417 NSCLC cases and 368 controls.
  • Stage 2 (Validation): A separate case-control study was performed in Tianjin, China, with 282 NSCLC cases and 282 controls, using propensity score matching to adjust for potential confounders.
  • Statistical Analysis: Chi-square tests and multivariate logistic regression were used to assess the association between SNPs and NSCLC risk, adjusting for factors like age and family history of cancer. Hardy-Weinberg equilibrium was checked in controls.
  • Gene Expression Analysis: Publicly available gene expression datasets (GSE32863, GSE37764, GSE11969, GSE13213) were analyzed to examine UGT2B7 mRNA expression in tumor tissues compared to normal tissues and to assess its association with overall survival in NSCLC patients.

Datasets

  • Gene Expression Datasets:
    • GSE32863 and GSE37764: Used to explore UGT2B7 expression in tumor and adjacent normal tissues from lung adenocarcinoma patients (including Asian never-smoking women and Korean never-smoking women).
  • GSE11969 and GSE13213: Used to explore the relationship between UGT2B7 expression and lung cancer diagnosis in never-smoking Japanese women with EGFR mutations.
  • SNP Genotyping Data: Collected from two independent cohorts of never-smoking Chinese women in Shenyang (training set) and Tianjin (validation set).
  • Public Databases: NCBI dbSNP and the 1000 Genomes Project were used for SNP selection.

Key Insights and Ideas

  • UGT2B7 as a Key Player: The study strongly implicates the UGT2B7 gene, which is involved in the metabolism of sex hormones like estrogens, as a potential contributor to lung cancer risk in women. This aligns with the hypothesis that sex hormones play a role in lung cancer development.
  • rs12233719 as a Risk Factor: The specific SNP rs12233719, a missense variant within UGT2B7, was consistently associated with an increased risk of NSCLC in never-smoking Chinese women across both the training and validation sets. This suggests a direct genetic link.
  • Mechanism of Action (Hypothesized): The G>T transversion at rs12233719 leads to an amino acid change (Ala71 to Ser71) in the UGT2B7 protein. This alteration is hypothesized to affect the protein's physical and chemical properties, potentially impacting its expression or enzymatic activity in metabolizing sex hormones, thereby influencing cancer susceptibility.
  • UGT2B7 Upregulation in Tumors: The study found that UGT2B7 mRNA was upregulated in tumor tissues of NSCLC patients, and higher expression was associated with poorer overall survival, suggesting a role in cancer progression.

Key Results

  • The SNP rs12233719 was significantly associated with an increased risk of never-smoking NSCLC in Chinese women.
  • In the Shenyang training set, the adjusted OR for the dominant model (TG+TT genotypes) was 1.58 (95% CI: 1.15–2.16).
  • In the Tianjin validation set, the adjusted OR for the dominant model was 1.49 (95% CI: 1.02–2.18).
  • A meta-analysis of both sets showed a combined OR of 1.54 (95% CI: 1.21–1.96) for the dominant model.
  • The SNP rs7439366 showed no significant association with never-smoking female NSCLC risk in this study.
  • UGT2B7 mRNA was significantly upregulated in NSCLC tumor tissues compared to adjacent normal tissues (p = 0.012).
  • High UGT2B7 expression was associated with significantly poorer overall survival in never-smoking Asian lung adenocarcinoma patients with EGFR mutation (HR = 4.80, 95% CI = 1.18–14.21, p = 0.027).

Limitations and Future Work

  • In Vitro/In Vivo Experiments: The study acknowledges the lack of functional experiments (in vivo or in vitro) to directly confirm the relationship between rs12233719 and SHBG concentrations or its precise impact on UGT2B7 activity.
  • Confounder Assessment: While age and family history were adjusted for, other potential confounders like menopause status, which is closely linked to women's lung cancer risk, could not be assessed due to limited data.
  • Sample Size and Prospective Estimation: The study did not prospectively estimate sample size for the case-control and transcriptome sequencing experiments. The transcriptome sequencing was based on a limited number of samples (11 pairs).
  • Population Specificity: The findings are limited to Chinese women and should be interpreted cautiously in other populations.
  • Future Directions: The authors suggest that larger studies, especially prospective ones, are warranted. They also plan to expand the sample size in future work and emphasize the need for functional experiments to elucidate the underlying mechanisms of rs12233719's impact on NSCLC.

Summary updated

Abstract

Our findings indicated that a sex hormones regulation-related SNP rs12233719 was associated with never-smoking female lung cancer risk, which might partially explain NSCLC-susceptibility in Chinese women.
BibTeX
@inproceedings{qian2021association,
  author = {Ying Qian and Li Xie and Lei Li and Tienan Feng and Tengteng Zhu and Ruoyang Wang and Yuqing Yang and Baosen Zhou and Herbert Yu and Biyun Qian},
  title = {{Association between sex hormones regulation‐related SNP rs12233719 and lung cancer risk among never‐smoking Chinese women}},
  booktitle = {Cancer},
  year = {2021},
  doi = {10.1002/cam4.3772},
}
Figure